NCT05018871
Safety of Cultured Umbilical or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for CP
StatusWithdrawn
PhasePhase 1
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
See every version on ClinicalTrials.gov ↗
- Stopped Trial status changed: Recruiting → Withdrawn Sponsor's reason: Duplicate registration; study is registered and actively tracked under NCT05018819. No participants were enrolled under this record.
- Stopped Trial status: Recruiting to Suspendedv2
- Stopped: terminated, suspended or withdrawn
Endpoints
Primary
Safety (adverse events)
Timeframe: Four year follow-up
Secondary (1)
Efficacy: Gross Motor Function Measure (GMFM)
Arms and interventions
Treatment GroupExperimental
Single intravenous infusion of 100 million cells
Biologicals: Umbilical or placental derived mesenchymal stem cells
Sites
2 sites in 2 countries
Greece 1, United States 1